During the past five years, circulatory effects of intravenous hexamethonium have been studied in normal subjects and in patients with various cardiac diseases (1-10). With adequate doses of the drug a significant reduction of the systemic blood pressure was observed in almost all cases. In many patients, particularly those with pulmonary hypertension, a reduction of the pulmonary artery pressure was also seen. However, the pulmonary "capillary" or pulmonary artery wedge pressures were recorded in only a small number of cases and changes of resistances in the pulmonary circuit were seldom studied.
During the past five years, circulatory effects of intravenous hexamethonium have been studied in normal subjects and in patients with various cardiac diseases (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . With adequate doses of the drug a significant reduction of the systemic blood pressure was observed in almost all cases. In many patients, particularly those with pulmonary hypertension, a reduction of the pulmonary artery pressure was also seen. However, the pulmonary "capillary" or pulmonary artery wedge pressures were recorded in only a small number of cases and changes of resistances in the pulmonary circuit were seldom studied.
The purposes of this paper are: 1) to report the hemodynamic effects of hexamethonium in a series of patients with mitral stenosis, 2) to discuss the probable mechanism of the changes of the resistances and pressures in the pulmonary circuit of these patients, and 3) to stress the therapeutic benefit of hexamethonium in patients with acute pulmonary edema secondary to mitral stenosis.
CLINICAL MATERIAL AND METHOD
Twenty-seven patients with predominant mitral stenosis were studied. There were 10 males and 17 females. Their ages ranged from 13 to 58 years. None of the patients had a significant degree of mitral insufficiency, a demonstrable lesion of other valves, or systemic hypertension.
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The patients were studied two to three hours after a light breakfast. In all cases 100 to 200 mg. of methyprylon (Noludar®) 5 was given by mouth as premedication.
The methods of determining the cardiac output and recording blood pressures have been described in detail in several previous papers (11) (12) (13) (14) . The formulae used to derive the resistances and ventricular work against pressures and mitral valve flow were adopted from the papers by Gorlin' and his co-workers (15, 16) . The mean pressures were measured by planimetric integration. Pulmonary "capillary" pressure was substituted for pulmonary venous and left atrial pressures. Pulmonary vascular resistance is the resistance between pulmonary artery and pulmonary vein. Total pulmonary resistance is the resistance between pulmonary artery and a hypothetical sink at atmospheric pressure. The difference between total pulmonary resistance and pulmonary vascular resistance is termed "left heart resistance" instead of "mitral valve resistance" (17, 18) . It includes the resistance at the mitral valve as well as the resistance to filling offered by the left ventricle in diastole. In patients with pure mitral stenosis, however, most of the calculated value is ascribable to resistance at the valve itself.
The right ventricular diastolic pressure was used in calculating the right ventricular work against pressure. In most cases right ventricular diastolic pressure was only recorded after hexamethonium administration and this was used for calculation of the work both before and after the drug. In several cases the control right ventricular diastolic pressure was little different from the value after injection. It was felt that the error would be small in calculating right ventricular work against pressure by using only the value following injection.
In calculating left ventricular work against pressure, the left ventricular diastolic pressure was assumed to be 5 mm. Hg in each case, because no left ventricular pressure was obtained at the time of cardiac catheterization. The calculation was discarded in five patients whose left ventricular diastolic pressure was later found, at operation, to exceed 8 mm. Hg.
After control measurements of cardiac output and femoral and pulmonary artery pressures (in all patients) and of pulmonary "capillary" pressure (in all but three 5 Courtesy of Hoffman LaRoche Company, Nutley, N. J. Table I .
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t The symbol of "p" indicates the probability that a difference as large as that observed will occur by chance. Throughout the discussion, a difference with a chance probability of 0.05 or less is considered to be significant. 
RESULTS
The results are given in detail in Table I and  summarized in Tables II and III . It will be seen from Table II that following hexamethonium injection there were statistically significant decreases in femoral artery pressure, pulmonary artery pressure, and pulmonary "capillary" pressure, but no statistically significant changes in cardiac index, stroke index, heart rate, pulmonary artery to pulmonary "capillary" pressure gradient and pulmonary vascular resistance. The total systemic, total pulmonary, "left heart" resistances ( Figure  1) , and the work of each ventricle against pressure were all statistically significantly reduced. The incidence of individually significant changes in these determinants is given in Table III. The decrease in pulmonary artery pressure usually occurred within 10 minutes of the start of the injection, and at the same time as, or shortly following, the fall in femoral artery pressure. The systolic pressure in the pulmonary artery was more affected than the diastolic. The fall in mean pres- sure was, in most cases, proportionally similar in the pulmonary and femoral arteries.
The decrease in pulmonary "capillary" pressure was also roughly proportional. in most cases, to the decrease in the femoral artery pressure. The change in pulmonary "capillary" pressure was unrelated to changes in flow, whether the latter was expressed per minute, per heart beat, or per second of diastolic time (Figure 2 ). It was also unrelated to the change in pulmonary vascular resistance. The "capillary" pressure changes were significantly positively correlated with the changes in "left heart resistance," left ventricular work against pressure, and right ventricular work against pressure.
Use of intravenous hexamethonium in pulmonary edema Intravenous hexamethonium was used clinically with excellent response in treating acute pulmonary edema in three patients with mitral stenosis. In two additional patients with mitral stenosis, acute pulmonary edema which developed during cardiac catheterization was promptly controlled after the injection of hexamethonium through the catheter. In 
DISCUSSION
Our results are in agreement with several reports that ganglionic blocking agents, given to patients with mitral stenosis, reduce the pulmonary artery and pulmonary "capillary" pressures without significantly altering the flow (5, 9, 10, 19) . This pattern is different from that commonly observed in normal animals (20, 21) , in patients without cardiorespiratory disease (4) , and in a variety of cardiorespiratory diseases other than mitral stenosis (1, 6, 8, 22 Only five of our patients were found later to have abnormally high left ventricular diastolic pressures, and these were not those who had the most marked drops of pulmonary "capillary" pressure at catheterization.
Nevertheless, a decline of this pressure follow-ing hexamethonium has been noted in normal dogs (19) and it would, of course, permit a similar drop to occur in the left atrial pressure without reducing the flow. Intrapulmonary shunts connecting the pulmonary vein to the azygos vein and right atrium by way of varicose anastomoses with the bronchial vein are known to exist in mitral stenosis (23) . When the pulmonary veins of one lung are ligated in dogs, such anastomoses may carry up to 20 per cent of the normal flow for that lung, so that azygos vein blood resembles arterial blood (24) . If such anastomoses in mitral stenosis patients were subject to dilation by hexamethonium, as systemic veins appear to be, then the paradox could be explained, as would the difference in response between mitral stenosis and other diseases. The increased low-pressure runoff would probably lower pulmonary venous pressure, which in turn would reduce the flow through the mitral valve. The shunted arterialized blood would recirculate through the lungs. The change in pulmonary flow, as we measured it, might therefore be nil, or even an increase, depending on the balance between increase in shunt flow and decrease in mitral valve flow.
Among other explanations we have discarded an actual reduction of mitral valve resistance as highly unlikely on structural grounds. It is true that marked slowing of the heart rate was associated with the largest decrease in pulmonary "capillary" pressure per unit flow. However, the overall change in heart rate was insignificant, and even when the length of diastole is taken into account, there were no flow changes to correlate with the alterations in pressure (Figure 2 ). Lastly, it seems unlikely that we are dealing with vasomotor changes in the recently postulated zone of resistance in the pulmonary venous bed (25) .
The decline in pulmonary vascular resistance, which was noted in six cases, it not likely to result passively from the lowering of left atrial pressure, since this should have the opposite effect (26) . Neither does it seem likely to be due to a vasodilator reflex from pressure receptors in the pulmonary capillary-venous bed (9) , since the changes were unrelated to changes in pulmonary "capillary" pressure. It is possible that it was caused by ganglionic blockade of the pulmonary arteriolar bed (2, 5, 19) . SUM MARY 1. Hexamethonium bromide was administered through a catheter into the pulmonary artery of 27 patients with mitral stenosis in doses sufficient to produce an initial depression of about 30 mm. Hg in the systolic pressure in the brachial artery.
2. Over the course of the following half-hour to one hour, changes in cardiac output, heart rate and stroke volume were insignificant.
3. The pulmonary artery pressure declined significantly in over half the cases, and the change was roughly proportional to the change in systemic artery pressure. The pulmonary "capillary" pressure also fell in more than two-thirds of observations. There was no consistent change in the PAm-"PC"m gradient, although pulmonary vascular resistance fell in a few instances.
4. The paradox of declining pulmonary "capillary" pressure with constant cardiac output is discussed. On hydraulic grounds it is unlikely that this could be explained solely by any vasomotor changes in the lung vessels or by passive shifts of blood from pulmonary to peripheral reservoirs, although both these may occur in addition. Changes in heart rate may play a small contributing role. Two other possible explanations are discussed: changes in left ventricular diastolic pressure, and increases in the transport of blood through intrapulmonary vascular shunts.
5. The clinical importance of the action of hexamethonium on the pressure in pulmonary circuit is illustrated by two cases of its successful use in the treatment of acute pulmonary edema which developed in patients with mitral stenosis during cardiac catheterization.
